|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao X, Li X and Yuan H: microRNAs in
gastric cancer invasion and metastasis. Front Biosci (Landmark Ed).
18:803–810. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu G, Jiang C, Li D, Wang R and Wang W:
MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in
gastric cancer. Tumour Biol. 35:9801–9806. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsuoka T and Yashiro M: Biomarkers of
gastric cancer: Current topics and future perspective. World J
Gastroenterol. 24:2818–2832. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang G, Yan J, Gu Y, Qiao M, Fan R, Mao Y
and Tang X: Construction of short tandem target mimic (STTM) to
block the functions of plant and animal microRNAs. Methods.
58:118–125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Muhammad S, Kaur K, Huang R, Zhang Q, Kaur
P, Yazdani HO, Bilol MU, Zheng J, Zheng L and Wang XS: MicroRNAs in
colorectal cancer: Role in metastasis and clinical perspectives.
World J Gastroenterol. 20:17011–17019. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chan B, Manley J, Lee J and Singh SR: The
emerging roles of microRNAs in cancer metabolism. Cancer Lett.
356((2 Pt A)): 301–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Romero-Cordoba SL, Salido-Guadarrama I,
Rodriguez-Dorantes M and Hidalgo-Miranda A: miRNA biogenesis:
Biological impact in the development of cancer. Cancer Biol Ther.
15:1444–1455. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang WT and Chen YQ: Circulating miRNAs in
cancer: From detection to therapy. J Hematol Oncol. 7:862014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faam B, Ghaffari MA, Ghadiri A and Azizi
F: Epigenetic modifications in human thyroid cancer. Biomed Rep.
3:3–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Pickard K, Jenei V, Bullock MD,
Bruce A, Mitter R, Kelly G, Paraskeva C, Strefford J, Primrose J,
et al: miR-153 supports colorectal cancer progression via
pleiotropic effects that enhance invasion and chemotherapeutic
resistance. Cancer Res. 73:6435–6447. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hua HW, Jiang F, Huang Q, Liao Z and Ding
G: MicroRNA-153 promotes Wnt/β-catenin activation in hepatocellular
carcinoma through suppression of WWOX. Oncotarget. 6:3840–3847.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bi CW, Zhang GY, Bai Y, Zhao B and Yang H:
Increased expression of miR-153 predicts poor prognosis for
patients with prostate cancer. Medicine (Baltimore). 98:e167052019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao W, Yin CY, Jiang J, Kong W, Xu H and
Zhang H: MicroRNA-153 suppresses cell invasion by targeting SNAI1
and predicts patient prognosis in glioma. Oncol Lett. 17:1189–1195.
2019.PubMed/NCBI
|
|
16
|
Guo G, Zhang Y, Hu L and Bian X:
MicroRNA-153 affects nasopharyngeal cancer cell viability by
targeting TGF-β2. Oncol Lett. 17:646–651.
2019.PubMed/NCBI
|
|
17
|
Wang J, Liang S and Duan X: Molecular
mechanism of miR-153 inhibiting migration, invasion and
epithelial-mesenchymal transition of breast cancer by regulating
transforming growth factor beta (TGF-β) signaling pathway. J Cell
Biochem. 120:9539–9546. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang B, Fu T and Zhang L: MicroRNA-153
suppresses human laryngeal squamous cell carcinoma migration and
invasion by targeting the SNAI1 gene. Oncol Lett. 16:5075–5083.
2018.PubMed/NCBI
|
|
19
|
Wu X, Li L, Li Y and Liu Z: MiR-153
promotes breast cancer cell apoptosis by targeting HECTD3. Am J
Cancer Res. 6:1563–1571. 2016.PubMed/NCBI
|
|
20
|
Najtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA;
WHO Classification of Tumours Editorial Board, : The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sano T, Coit DG, Kim HH, Roviello F,
Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new
stage grouping of gastric cancer for TNM classification:
International Gastric Cancer Association staging project. Gastric
Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou J, Xie M, Shi Y, Luo B, Gong G, Li J,
Wang J, Zhao W, Zi Y, Wu X and Wen J: MicroRNA-153 functions as a
tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer
cells. Oncol Rep. 34:111–120. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luan W, Shi Y, Zhou Z, Xia Y and Wang J:
circRNA_0084043 promote malignant melanoma progression via
miR-153-3p/Snail axis. Biochem Biophys Res Commun. 502:22–29. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murai T, Yamada S, Fuchs BC, Fujii T,
Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK and Kodera
Y: Epithelial-to-mesenchymal transition predicts prognosis in
clinical gastric cancer. J Surg Oncol. 109:684–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang ZY and Ge HY: Micrometastasis in
gastric cancer. Cancer Lett. 336:34–45. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu Q, Sun Q, Zhang J, Yu J, Chen W and
Zhang Z: Downregulation of miR-153 contributes to
epithelial-mesenchymal transition and tumor metastasis in human
epithelial cancer. Carcinogenesis. 34:539–549. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Sun J, Bai Z, Li H, He S, Chen R
and Che X: MicroRNA-153 acts as a prognostic marker in gastric
cancer and its role in cell migration and invasion. Onco Targets
Ther. 8:357–364. 2015.PubMed/NCBI
|
